ARTICLE | Company News
Cellectis, genOway deal
February 10, 2014 8:00 AM UTC
Cellectis granted genOway an exclusive sublicense to Cellectis' homologous recombination technology for research applications in genetically modified rodents. Under the deal, genOway will be the exclusive service provider and distributor of the technology to academic and industry scientists in the field of genetically modified rodent models. Cellectis remains the partner for other applications, such as bioproduction and therapeutics. The companies are not disclosing financial terms. ...